Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
Text Size
63 studies found for:    hypercoagulation OR thrombophilia OR blood clotting | Open Studies | NIH, U.S. Fed

Modify this search | How to Use Search Results

Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Cancel
Rank Status Study
1 Recruiting Blood Markers of Inflammation, Blood Clotting and Blood Vessel Function in HIV-infected Adults
Condition: HIV
Intervention:
2 Recruiting The Genetics and Functional Basis of Inherited Platelet, White Blood Cell, Red Blood Cell, and Blood Clotting Disorders.
Condition: Glanzmann Thrombasthenia
Intervention:
3 Recruiting Understanding the Role of Genes and Biomarkers in the Blood Clotting Process in Children With Acute Lung Injury
Condition: Respiratory Distress Syndrome, Adult
Intervention:
4 Recruiting ART and Inflammatory and Coagulation Biomarkers
Conditions: HIV (Human Immunodeficiency Virus);   AIDS (Acquired Immune Deficiency Syndrome);   Tuberculosis;   Non-communicable Diseases (NCD)
Intervention:
5 Recruiting Coagulation and Fibrinolysis in Pediatric Insulin Titration Trial (CAF-PINT)
Conditions: Heart Failure;   Respiratory Failure
Intervention:
6 Recruiting The Interaction of Two HIV Medications With Blood Clot Medications in Healthy Volunteers
Condition: HIV
Interventions: Drug: Ritonavir;   Drug: Cobicistat
7 Recruiting Safety of Endoscopic Resection of Large Colorectal Polyps: A Randomized Trial.
Condition: Colon Polyps
Intervention: Procedure: Clip closure
8 Recruiting Alcohol's Impact on Inflammatory Markers in HIV Disease - Russia ARCH Cohort
Conditions: HIV Infection;   Alcohol Use
Intervention:
9 Recruiting Topical or Ablative Treatment in Preventing Anal Cancer in Patients With HIV and Anal High-Grade Squamous Intraepithelial Lesions
Conditions: Anal Cancer;   High-grade Squamous Intraepithelial Lesion;   HIV Infection;   Human Papilloma Virus Infection
Interventions: Drug: imiquimod;   Drug: fluorouracil;   Procedure: infrared photocoagulation therapy;   Procedure: thermal ablation therapy;   Procedure: laser therapy;   Other: clinical observation;   Other: laboratory biomarker analysis;   Procedure: quality-of-life assessment
10 Recruiting Decitabine for High-Risk Sickle Cell Disease
Conditions: Neutropenia;   Sickle Cell Disease
Intervention: Drug: Decitabine
11 Recruiting The Interaction of Social Factors With Air Pollution
Condition: Exposure to Environmental Pollution, Non-occupational
Interventions: Other: Clean Air;   Other: Ozone
12 Recruiting Phase 1 Safety Study of Dimethyl Sulfoxide Cryopreserved Platelets
Condition: Thrombocytopenia
Interventions: Biological: CPP;   Biological: LSP
13 Recruiting Elite Controller and ART-treated HIV+ Statin Versus ASA Treatment Intervention Study
Condition: HIV Infection
Interventions: Drug: Aspirin 81 mg daily;   Drug: Atorvastatin 40 mg daily
14 Recruiting Prasugrel for Prevention of Early Saphenous Vein Graft Thrombosis
Condition: Coronary Artery Bypass
Interventions: Drug: Prasugrel;   Drug: Placebo
15 Recruiting Personalized Medicine Decision-Making in a Virtual Clinical Setting
Conditions: Deep Vein Thrombosis;   Blood Clots
Intervention:
16 Recruiting Use of Phytonadione to Reduce International Normalized Ratio (INR) Variability in Patients on Long-term Warfarin Therapy
Condition: Coagulation Delay
Interventions: Dietary Supplement: phytonadione;   Drug: none-control group
17 Unknown † Observational Study of Sepsis and Pneumonia to Develop Diagnostic Tests
Conditions: Sepsis;   Septicemia;   Sepsis Syndrome;   Shock, Septic;   Community Acquired Pneumonia
Intervention:
18 Recruiting Chronology of Occult and Gross Coagulopathy in Burn Patients
Condition: Thermal Burns
Intervention:
19 Recruiting Control of Major Bleeding After Trauma Study
Conditions: Trauma;   Hemorrhagic Shock
Interventions: Biological: Type AB plasma;   Drug: Crystalloid fluid (standard of care for resuscitation)
20 Recruiting Pegylated Interferon Alfa-2a Salvage Therapy in High Risk Polycythemia Vera (PV) or Essential Thrombocythemia (ET)
Conditions: High Risk Polycythemia Vera;   High Risk Essential Thrombocythemia
Interventions: Drug: PEGASYS;   Drug: Aspirin
To Top

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
† Indicates status has not been verified in more than two years